FDMT
4D Molecular Therapeutics, Inc.Company with tickers: FDMT
CIK
1650648
CUSIP
35104E100
Shares Outstanding
52,276,254
13F Activity (30d)
107 filings
104 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-12-16 | SCOTT BIZILY | Officer | 1,635 | 2025-12-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-17 | SCOTT BIZILY | Officer | 1,635 | 2025-11-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-24 | SCOTT BIZILY | Officer | 1,816 | 2025-10-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-23 | SCOTT BIZILY | Officer | 7,312 | 2025-09-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-07-01 | SCOTT BIZILY | Officer | 9,498 | 2024-07-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-04-01 | SCOTT BIZILY | Officer | 13,403 | 2024-04-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-02-08 | SCOTT BIZILY | Officer | 17,738 | 2024-02-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-04-21 | Jacob Chacko | Affiliate | 15,000 | 2023-04-21 | JPMorgan Securies LLC |
| 2023-04-21 | Scott Bizily | Officer | 9,747 | 2023-04-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–9 of 9 filings